DW71177
DW71177 is a novel [1,2,4]triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor, and can be used for study of acute myeloid leukemia[1].
Product Specifications
CAS Number
[2241311-72-6]
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dw71177.html
Purity
97.70
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC1=NN=C2C(NCCCCNC(CC(C)C)=O)=NC3=CC(OC)=CC=C3N21
Molecular Formula
C20H28N6O2
Molecular Weight
384.48
References & Citations
[1]Ali I, et al. DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia. Eur J Med Chem. Published online December 16, 2023.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS8807027-01 48 Well
Human Anti-MBL (Anti-Mannose Binding Lectin Antibody) ELISA Kit
Ask
View Details 
MBS8807027-02 96 Well
Human Anti-MBL (Anti-Mannose Binding Lectin Antibody) ELISA Kit
Ask
View Details MBS8807027-03 5x 96 Well
Human Anti-MBL (Anti-Mannose Binding Lectin Antibody) ELISA Kit
Ask
View Details MBS8807027-04 10x 96 Well
Human Anti-MBL (Anti-Mannose Binding Lectin Antibody) ELISA Kit
Ask
View Details 